Raynar Prime

RN PRIME (Raynar Prime) has been registered as a broker in Australia since 2022 and is poised to provide high-quality, compliant trading services to professional and institutional traders in the Foreign Exchange (FX), Commodities and Contracts for Difference (CFD) markets with a wholesale-market focus.

The company was established in Melbourne, Australia and holds an AFS licence (no: 001300954), which allows it to operate commercially within Australia. RN PRIME is a new broker and is targeting the fast-growing professional marketplace with an extensive range of trading technologies, an extensive range of products and strong regulatory oversight.

RN PRIME's primary areas of expertise are wholesale FX, Commodities and CFDs.

At this time, specific information regarding account-matching capabilities or any unique features on the RN PRIME platform are lacking, however, it does promote execution capabilities, hardware and software that are suitable for high-volume traders.

RN PRIME is regulated by the Australian Securities and Investments Commission and has full ability to conduct business in line with Australian law through its AFS licence.

Trading conditions and technology offered by RN PRIME include but are not limited to:

– Spreads: Not disclosed to the public, however, are likely competitive;

– Leverage: Not disclosed to the public but specifically designed around the needs of wholesale clients;

– Minimum deposit: Not available for public viewing; however, will be consistent with institutional deposit standards;

– Platform technology: Utilises proprietary institutional level technologies, but no names disclosed.

The RN PRIME Fee Structure includes the following fees:

– Deposit Fees: Not publicly available; however, they will vary depending on individual agreements;

– Withdrawal Fees: Not publicly available; however, they will vary depending on individual agreements;

– Commissions: Anticipated to be based on volume and negotiable based on client volume;

– Inactivity Fees: Information not available.

Publicly available reviews of RN PRIME are currently scarce due to its mainly institutional client-base; however, it does have a high level of regulatory oversight provided by ASIC.

Since 2022 there has not been a significant public event or product expansion in support of RN PRIME. The company appears to be focused on strengthening its own internal capacity and business footprint.

As a new broker, RN PRIME is able to provide a regulated compliant environment for wholesale and professional traders in FX, Commodities and CFDs. Because of limited information regarding corporate trading terms and fees, interested parties are encouraged to contact RN PRIME directly to obtain tailored conditions and platform information.